Close Menu

J&J

Nanosphere has appointed Roy Davis to its board of directors. Davis worked for Johnson & Johnson for nearly three decades before he retired this January.

Despite its relatively low profile since it kicked off its third phase last spring, the Broad Institute's RNAi Consortium is proceeding apace, although its mission has expanded beyond its initial focus of just RNAi.

NEW YORK (GenomeWeb News) – Everist Genomics today said that it will open a lab within Johnson & Johnson's Janssen Labs innovation center in San Diego.

Protein biomarker diagnostics firm Astute Medical this week said it had completed a Series C financing round that raised $40.4 million.

This article originally ran on May 15 and has been updated to include additional comments from GlaxoSmithKline.
GlaxoSmithKline said today that it has entered an agreement to purchase chemical proteomics firm Cellzome for £61 million ($99 million).

By Adam Bonislawski
University of North Carolina researchers have developed a chemical proteomics approach to measure global kinase activity and used it to investigate drug resistance in triple-negative breast cancer.

Belgian protein biomarker firm Pronota has raised €3.7 million ($4.9 million) a Series C financing round that it will use to complete protein biomarker validation studies for its pre-eclampsia, ovarian cancer, sepsis, and cardio-renal programs.

Title: Gene Silencing
Patent Number: 8,097,710
Filed: March 22, 2004
Lead Inventor: David Baulcombe, Plant Bioscience

Foundation Medicine has struck a deal with Johnson & Johnson Pharmaceutical Research and Development to use Foundation's targeted sequencing cancer test to identify potential biomarkers that could be of interest for the pharmaceutical company's clinical oncology programs.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Foundation Medicine today said that it will partner with Johnson & Johnson Pharmaceutical Research and Development in a biomarker identification collaboration.

Pages

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.